XML 113 R98.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Revenue from Segments to Consolidated (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues [1] $ 319,939 $ 222,057 $ 616,996 $ 437,128
Adjusted EBITDA 21,739 13,346 45,994 28,253
Evolent Health Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 92,336 74,863 199,194 159,700
Clinical Solutions        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 227,603 147,194 417,802 277,428
Intersegment Eliminations        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues (460) (460) (920) (898)
Operating Segments        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 319,939 222,057 616,996 437,128
Adjusted EBITDA 28,621 20,128 59,034 42,046
Operating Segments | Evolent Health Services        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 92,796 75,323 200,114 160,609
Adjusted EBITDA 15,129 6,531 23,346 12,473
Operating Segments | Clinical Solutions        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 227,603 147,194 417,802 277,417
Adjusted EBITDA 13,492 13,597 35,688 29,573
Corporate        
Segment Reporting, Revenue Reconciling Item [Line Items]        
Revenues 0 0 0 0
Adjusted EBITDA $ (6,882) $ (6,782) $ (13,040) $ (13,793)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.